Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

Robert R Zielinski; Arun Azad; Kim N Chi; Scott Tyldesely

doi:10.5489/cuaj.2076

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

Robert R Zielinski, Arun Azad, Kim N Chi, Scott Tyldesely

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Pages (from-to)	520-523
Number of pages	4
Journal	Canadian Urological Association Journal
Volume	8
Issue number	7-8
DOIs	https://doi.org/10.5489/cuaj.2076
Publication status	Published - 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5489/cuaj.2076

2582863-oaFinal published version, 174 KB

Cite this

@article{1cd231f28677456aa65cbebe9be9b1fd,

title = "Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer",

author = "Zielinski, {Robert R} and Arun Azad and Chi, {Kim N} and Scott Tyldesely",

year = "2014",

doi = "10.5489/cuaj.2076",

language = "English",

volume = "8",

pages = "520--523",

journal = "Canadian Urological Association Journal",

issn = "1920-1214",

publisher = "Canadian Urological Association Journal",

number = "7-8",

}

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer. / Zielinski, Robert R; Azad, Arun; Chi, Kim N; Tyldesely, Scott.

In: Canadian Urological Association Journal, Vol. 8, No. 7-8, 2014, p. 520-523.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

AU - Zielinski, Robert R

AU - Azad, Arun

AU - Chi, Kim N

AU - Tyldesely, Scott

PY - 2014

Y1 - 2014

UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137017/pdf/cuaj-7-8-e520.pdf

U2 - 10.5489/cuaj.2076

DO - 10.5489/cuaj.2076

M3 - Article

VL - 8

SP - 520

EP - 523

JO - Canadian Urological Association Journal

JF - Canadian Urological Association Journal

SN - 1920-1214

IS - 7-8

ER -

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this